The National Institute of Environmental Health Sciences reports that autoimmune diseases impact approximately 1 in 10 individuals worldwide, with a higher prevalence among women (13%) compared to men (7%). The spectrum of autoimmune diseases encompasses over 80 different types, including well-recognized conditions like Type 1 diabetes, where insulin-producing cells are targeted; Multiple Sclerosis, which attacks the protective covering of nerves; lupus, affecting tissues and organs; and rheumatoid arthritis, which targets the lining of joints. Additionally, several lesser-known autoimmune diseases have been identified. Notably, individuals diagnosed with one autoimmune condition are at an increased risk of developing another, suggesting shared genetic or environmental risk factors among some of these diseases.

Under normal circumstances, the immune system acts as the body's defense mechanism against foreign threats, such as infections. However, in the case of autoimmune diseases, this protective role is compromised, leading to the immune system mistakenly attacking the body's own healthy cells. The severity of symptoms varies and can significantly affect a person's health and well-being.

While most autoimmune diseases remain incurable, requiring ongoing management to alleviate symptoms, hyperbaric therapy has emerged as a promising non-invasive treatment option. This therapy can potentially reduce inflammation and pain, enhance the quality of life, and complement other treatment strategies, offering hope to those managing these challenging conditions.